Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Acquisitions (2018)

Historic Acquisitions for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q1 2018 value amounting to $76.3 million.

  • Rocket Pharmaceuticals' Acquisitions changed N/A to $76.3 million in Q1 2018 from the same period last year, while for Dec 2018 it was $76.3 million, marking a year-over-year change of. This contributed to the annual value of $42.7 million for FY2022, which is N/A changed from last year.
  • As of Q1 2018, Rocket Pharmaceuticals' Acquisitions stood at $76.3 million.
  • Rocket Pharmaceuticals' 5-year Acquisitions high stood at $76.3 million for Q1 2018, and its period low was $76.3 million during Q1 2018.